222 related articles for article (PubMed ID: 36219557)
21. Generation of infectious recombinant Adeno-associated virus in Saccharomyces cerevisiae.
Barajas D; Aponte-Ubillus JJ; Akeefe H; Cinek T; Peltier J; Gold D
PLoS One; 2017; 12(3):e0173010. PubMed ID: 28355224
[TBL] [Abstract][Full Text] [Related]
22. Molecular design of controllable recombinant adeno-associated virus (AAV) expression systems for enhanced vector production.
Johari YB; Pohle TH; Whitehead J; Scarrott JM; Liu P; Mayer A; James DC
Biotechnol J; 2024 Jun; 19(6):e2300685. PubMed ID: 38900035
[TBL] [Abstract][Full Text] [Related]
23. Replication competent helper functions for recombinant AAV vector generation.
Cao L; During M; Xiao W
Gene Ther; 2002 Sep; 9(18):1199-206. PubMed ID: 12215886
[TBL] [Abstract][Full Text] [Related]
24. Optimised helper virus-free production of high-quality adeno-associated virus vectors.
Drittanti L; Jenny C; Poulard K; Samba A; Manceau P; Soria N; Vincent N; Danos O; Vega M
J Gene Med; 2001; 3(1):59-71. PubMed ID: 11269337
[TBL] [Abstract][Full Text] [Related]
25. Towards a scalable bioprocess for rAAV production using a HeLa stable cell line.
Escandell J; Moura F; Carvalho SB; Silva RJS; Correia R; Roldão A; Gomes-Alves P; Alves PM
Biotechnol Bioeng; 2023 Sep; 120(9):2578-2587. PubMed ID: 37027346
[TBL] [Abstract][Full Text] [Related]
26. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
27. Self-amplification system for recombinant adeno-associated virus production.
Urabe M; Shimazaki K; Saga Y; Okada T; Kume A; Tobita K; Ozawa K
Biochem Biophys Res Commun; 2000 Sep; 276(2):559-63. PubMed ID: 11027513
[TBL] [Abstract][Full Text] [Related]
28. Adeno-Associated Virus Monoinfection Induces a DNA Damage Response and DNA Repair That Contributes to Viral DNA Replication.
Ning K; Kuz CA; Cheng F; Feng Z; Yan Z; Qiu J
mBio; 2023 Feb; 14(1):e0352822. PubMed ID: 36719192
[TBL] [Abstract][Full Text] [Related]
29. HPV-16 E1, E2 and E6 each complement the Ad5 helper gene set, increasing rAAV2 and wt AAV2 production.
Cao M; Zhu H; Bandyopadhyay S; You H; Hermonat PL
Gene Ther; 2012 Apr; 19(4):418-24. PubMed ID: 21850053
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection.
Nambiar B; Cornell Sookdeo C; Berthelette P; Jackson R; Piraino S; Burnham B; Nass S; Souza D; O'Riordan CR; Vincent KA; Cheng SH; Armentano D; Kyostio-Moore S
Hum Gene Ther Methods; 2017 Feb; 28(1):23-38. PubMed ID: 28166648
[TBL] [Abstract][Full Text] [Related]
31. Development of Versatile and Flexible Sf9 Packaging Cell Line-Dependent OneBac System for Large-Scale Recombinant Adeno-Associated Virus Production.
Wu Y; Mei T; Jiang L; Han Z; Dong R; Yang T; Xu F
Hum Gene Ther Methods; 2019 Oct; 30(5):172-183. PubMed ID: 31566024
[TBL] [Abstract][Full Text] [Related]
32. Role for highly regulated rep gene expression in adeno-associated virus vector production.
Li J; Samulski RJ; Xiao X
J Virol; 1997 Jul; 71(7):5236-43. PubMed ID: 9188591
[TBL] [Abstract][Full Text] [Related]
33. A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors.
Clark KR; Voulgaropoulou F; Johnson PR
Gene Ther; 1996 Dec; 3(12):1124-32. PubMed ID: 8986439
[TBL] [Abstract][Full Text] [Related]
34. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
35. Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors.
Mohiuddin I; Loiler S; Zolotukhin I; Byrne BJ; Flotte TR; Snyder RO
Mol Ther; 2005 Feb; 11(2):320-6. PubMed ID: 15668144
[TBL] [Abstract][Full Text] [Related]
36. Novel strategy for generation and titration of recombinant adeno-associated virus vectors.
Shiau AL; Liu PS; Wu CL
J Virol; 2005 Jan; 79(1):193-201. PubMed ID: 15596815
[TBL] [Abstract][Full Text] [Related]
37. High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids.
Cao L; Liu Y; During MJ; Xiao W
J Virol; 2000 Dec; 74(24):11456-63. PubMed ID: 11090141
[TBL] [Abstract][Full Text] [Related]
38. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus.
Liu XL; Clark KR; Johnson PR
Gene Ther; 1999 Feb; 6(2):293-9. PubMed ID: 10435114
[TBL] [Abstract][Full Text] [Related]
39. Insect cells as a factory to produce adeno-associated virus type 2 vectors.
Urabe M; Ding C; Kotin RM
Hum Gene Ther; 2002 Nov; 13(16):1935-43. PubMed ID: 12427305
[TBL] [Abstract][Full Text] [Related]
40. Production of recombinant adeno-associated virus vectors.
Zolotukhin S
Hum Gene Ther; 2005 May; 16(5):551-7. PubMed ID: 15916480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
